SRD5A1 and posterior cortical atrophy: Based on this paradigm, this study highlights the critical role of the concerted interplay between testosterone metabolites HSD17B2, HSD17B3, SHBG, and SRD5A1 as reflective of disease status and as a surrogate biomarker of therapy response in patients with PCa.